Bristol Myers Squibb (BMY) EBITDA (2009 - 2026)
Bristol Myers Squibb's EBITDA came in at $3.16 billion for Q3 2026, down 23.3% from $4.13 billion a year earlier and down 32.4% from the prior quarter.
Bristol Myers Squibb (BMY) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Bristol Myers Squibb reported EBITDA of $14.12 billion, up 9.1% year-over-year; for FY2025, it came in at $13.34 billion, up 992.5% from FY2024.
- EBITDA carries a five-year compound annual growth rate of 30.6% (FY2020 to FY2025).
- Going back by year, EBITDA was $1.22 billion in FY2024 (-93.3%), $18.2 billion in FY2023 (+1.2%), $17.99 billion in FY2022 (-4.2%) and $18.78 billion in FY2021 (+435.3%).
- The five-year range for quarterly EBITDA is -$8.98 billion (Q1 2024) to $5.2 billion (Q1 2023).
- Year-over-year, EBITDA increased in two of the last seven quarters, with an average decline of 3.1%.
- The fastest year-over-year change in EBITDA over five years came in Q2 2026 (growth of 68.1%), and the weakest in Q4 2024 (a decline of 50.3%).
- Business Quant data shows BMY's EBITDA at $4.68 billion (Q2 2026), $3.83 billion (Q1 2026) and $2.45 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 3.16 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.16 Bn |
| Jun 30, 2026 | 4.68 Bn |
| Mar 31, 2026 | 3.83 Bn |
| Dec 31, 2025 | 2.45 Bn |
| Sep 30, 2025 | 4.13 Bn |
| Jun 30, 2025 | 2.78 Bn |
| Mar 31, 2025 | 3.98 Bn |
| Dec 31, 2024 | 2.06 Bn |
| Sep 30, 2024 | 4.27 Bn |
| Jun 30, 2024 | 3.88 Bn |
| Mar 31, 2024 | -8.98 Bn |
| Dec 31, 2023 | 4.14 Bn |
| Sep 30, 2023 | 4.57 Bn |
| Jun 30, 2023 | 4.29 Bn |
| Mar 31, 2023 | 5.20 Bn |
| Dec 31, 2022 | 4.38 Bn |
| Sep 30, 2022 | 4.80 Bn |
| Jun 30, 2022 | 4.54 Bn |
| Mar 31, 2022 | 4.27 Bn |
| Dec 31, 2021 | 4.44 Bn |
Bristol Myers Squibb EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();